We are live on ! Find out more
JNJ icon

Johnson & Johnson

3,790 hedge funds and large institutions have $326B invested in Johnson & Johnson in 2022 Q4 according to their latest regulatory filings, with 322 funds opening new positions, 1,605 increasing their positions, 1,494 reducing their positions, and 82 closing their positions.

New
Increased
Maintained
Reduced
Closed

293% more first-time investments, than exits

New positions opened: 322 | Existing positions closed: 82

12% more call options, than puts

Call options by funds: $3.5B | Put options by funds: $3.12B

11% more capital invested

Capital invested by funds: $295B → $326B (+$31.3B)

5% more funds holding

Funds holding: 3,6233,790 (+167)

7% more repeat investments, than reductions

Existing positions increased: 1,605 | Existing positions reduced: 1,494

0.88% more ownership

Funds ownership: 68.92%69.8% (+0.88%)

3% less funds holding in top 10

Funds holding in top 10: 730706 (-24)

Holders
3,790
Holders Change
+167
Holders Change %
+4.61%
% of All Funds
60.9%
Holding in Top 10
706
Holding in Top 10 Change
-24
Holding in Top 10 Change %
-3.29%
% of All Funds
11.35%
New
322
Increased
1,605
Reduced
1,494
Closed
82
Calls
$3.5B
Puts
$3.12B
Net Calls
+$377M
Net Calls Change
-$547M
Name Holding Trade Value Shares
Change
Change in
Stake
CCMINC
701
Cardinal Capital Management Inc (North Carolina)
North Carolina
$17.4M -$158K -914 -0.9%
RPC
702
Rossmore Private Capital
Connecticut
$17.4M +$246K +1,423 +1%
ECG
703
Edge Capital Group
Georgia
$17.4M +$552K +3,197 +3%
CPO
704
Cerity Partners OCIO
New York
$17.3M +$753K +4,363 +5%
APF
705
Alaska Permanent Fund
Alaska
$17.3M +$346K +2,006 +2%
TTWM
706
TCV Trust & Wealth Management
Virginia
$17.2M +$112K +647 +0.7%
PI
707
Pettee Investors
Connecticut
$17.2M +$22.6K +131 +0.1%
ECM
708
Estabrook Capital Management
New York
$17.1M -$148K -860 -0.9%
LCM
709
Logan Capital Management
Pennsylvania
$17.1M +$2.13M +12,349 +15%
M
710
MOTCO
Texas
$17.1M -$378K -2,191 -2%
Impax Asset Management Group
711
Impax Asset Management Group
United Kingdom
$17M -$2.88M -16,664 -15%
BG
712
Bollard Group
Massachusetts
$17M -$65.8K -381 -0.4%
LA
713
Lynch & Associates
Indiana
$17M -$97.9K -567 -0.6%
SGK
714
Steigerwald Gordon & Koch
Virginia
$16.9M +$370K +2,145 +2%
PAM
715
Private Asset Management
California
$16.9M +$364K +2,110 +2%
TA
716
TruWealth Advisors
Louisiana
$16.9M +$4.31M +24,971 +35%
VAS
717
Vestmark Advisory Solutions
Massachusetts
$16.9M +$436K +2,525 +3%
FFIC
718
First Fiduciary Investment Counsel
Ohio
$16.9M -$511K -2,958 -3%
MAM
719
Meeder Asset Management
Ohio
$16.8M -$10.6M -61,209 -39%
SBWIC
720
Schaper Benz & Wise Investment Counsel
Wisconsin
$16.7M -$735K -4,255 -4%
SIMG
721
Sonora Investment Management Group
Arizona
$16.7M +$1.34M +7,749 +9%
KRSITF
722
Kentucky Retirement Systems Insurance Trust Fund
Kentucky
$16.6M
AHC
723
Adell Harriman & Carpenter
Texas
$16.6M +$123K +714 +0.8%
PWMAG
724
Pinnacle Wealth Management Advisory Group
New Jersey
$16.5M -$73.2K -424 -0.5%
KPWS
725
Kestra Private Wealth Services
Texas
$16.4M +$326K +1,889 +2%

JNJ Hedge Fund Activity: Q4 2022 in Review

3,790 of the 6,223 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q4 2022, worth a combined $326B — up 11% from $295B a quarter earlier.

Buyers outnumbered sellers: 322 funds opened new JNJ positions and 82 closed out — a net gain of 240 holders — while 1,605 added to existing stakes and 1,494 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $781M. The largest seller was Marshall Wace, cutting an estimated $312M.

  • 3,790 institutional investors held Johnson & Johnson (JNJ) as of Q4 2022, up from 3,623 in Q3 2022.
  • Funds reported $326B of Johnson & Johnson stock for Q4 2022, up 11% quarter-over-quarter.
  • 322 funds opened new Johnson & Johnson positions in Q4 2022 and 82 closed out, a net change of +240 holders.
  • The largest Johnson & Johnson buyer in Q4 2022 was Morgan Stanley, an estimated $781M added.
  • The largest Johnson & Johnson seller in Q4 2022 was Marshall Wace, an estimated $312M sold.

Based on aggregated 13F filings for Q4 2022.